Abstract:BACKGROUND The use of Mechanical Circulatory Support (including Left ventricular assist devices) in patients with advanced Heart failure as a bridge-to-transplant or as a destination therapy has been linked to clinically significant 1- and 2- year survival rates. This study examines the trends of racial differences in the use of mechanical circulatory support devices (MCS) as well as some in-hospital outcomes. METHODS We identified all patients with Mechanical Circulatory Support (including Left ventricular assist devices) using ICD 10 codes from the national inpatient sample of the Health Care Utilization Project database, years 2016 - 2020. We classified our population into subgroups based on RACE (white, blacks, Hispanics and Asians). Using the chi-square test, we compared the differences in baseline characteristics amongst the racial subgroups and further used multivariate logistic regression to identify outcomes. RESULTS We observed about 95,430 patients with MCS. 73.2% were Whites, 14.3% Blacks, 9.4% Hispanics and 3.1% Asians and of these, Blacks were noted to have a younger mean age of 57 years. The population was composed highly of males than females across all races. AKI (64.1%), anemia (64.9%), obesity (21.33%) and OSA (13.0%), were all reported to be more common in Blacks than in other racial groups. Whites had greater rates of hypertension (14.9%) and nicotine use (25.8%) while Asians had higher rates of dyslipidemia (54.4%). Hispanics had higher rates of Diabetes (14.4%). Our black population had higher rates of cardiogenic shock (aOR: 0.88; 0.78 - 0.99, p=0.033), significantly longer mean length of stay (24.7 days vs 14.5 days, p<0.001) and higher hospital costs incurred ($750,083 vs $517,196, p<0.001) when compared to other racial groups. The most important independent predictor for the utilization of MCS was cardiogenic shock (aOR: 30.67; CI: 28.8 - 32.67, p<0.001); Asians (3.52%), Hispanics (2.58%) and blacks (2.20%) had higher rates than whites (2.13%). Between 2017 and 2020, Whites had the highest rates of Mechanical Circulatory support usage, with 0.78 per 1000 patients in 2020. Asians had the second highest usage rate with 0.69 per 1000 patients in 2020, while Blacks and Hispanics had lower but similar and stable rates during this period. CONCLUSION Despite having higher rates of cardiogenic shock (which is the independent predictor of MCS utilization) Blacks, Hispanics and Asians had lesser rates of MCS utilization. The findings from out study suggests that racial disparities persist in the use and outcomes of MCS, and efforts should be made to address these disparities and improve the care of patients with advanced heart failure across all racial groups.

Trends in Mechanical Circulatory Support utilization, Left Ventricular Assist Device implantation and Transplant during Cardiogenic Shock Hospitalizations, after the New Heart Allocation Policy

A challenge to equity in transplantation: Increased center-level variation in short-term mechanical circulatory support use in the context of the updated U.S. heart transplant allocation policy

Impact of Heart Transplant Allocation Change on Waitlist Mortality and Posttransplant Mortality in Patients With Left Ventricular Assist Devices

Three-Year Left Ventricular Assist Device Outcomes and Strategy After Heart Transplant Allocation Score Change

Impact of the New Heart Allocation System on the Medium-Term Outcomes in Patients With Hypertrophic Cardiomyopathy

Impact of the 2018 change in US allocation policy on adults with congenital heart disease

Impact of new allocation policy on waitlist and transplant outcomes of adult congenital heart patients supported with ECMO

US trends of in-hospital morbidity and mortality for acute myocardial infarctions complicated by cardiogenic shock

Trends and outcomes of different mechanical circulatory support modalities for acute myocardial infarction associated cardiogenic shock in patients undergoing early revascularization

Survival After Simultaneous Heart-kidney Transplant in Recipients With a Durable LVAD and Chronic Kidney Disease: Effect of the 2018 Heart Allocation Policy Change

Outcomes in Heart Transplant Recipients by Bridge to Transplant Strategy When Using the SherpaPak Cardiac Transport System

Trends Of Cardiogenic Shock And Percutaneous Left Ventricular Assist Device Utilization In Patients With ESRD

OPTN/SRTR 2021 Annual Data Report: Heart

The impact of the OPTN policy change on patients with a durable left ventricular assist device and chronic kidney disease: Analysis of the UNOS database

Mechanical circulatory support early after pediatric heart transplantation-an analysis from the Pediatric Heart Transplant Society

Revised Heart Allocation Policy Improved Waitlist Mortality and Waiting Time With Maintained Outcomes in En-Bloc Heart-Lung Transplant Candidates and Recipients

In-hospital Outcomes And Trends Of Racial Differences In Utilization Of Mechanical Circulatory Support

Trends in Mechanical Circulatory Support Use and Outcomes of Patients With Cardiogenic Shock in Japan, 2010 to 2020 (from a Nationwide Inpatient Database Study)

Regional differences in recipient waitlist time and pre- and post-transplant mortality after the 2006 United Network for Organ Sharing policy changes in the donor heart allocation algorithm

Temporary mechanical circulatory support devices: updates from recent studies

Extracorporeal membrane oxygenation bridge to heart transplant: Trends following the allocation change